Prognostic value of Holliday junction‑recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma

Chen,Long; Zeng,Chong; Yan,Limei; Liao,Wanyu; Zhen,Chen; Yao,Jie

doi:10.3892/ol.2022.13353

Prognostic value of Holliday junction‑recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma

Authors:
- Long Chen
- Chong Zeng
- Limei Yan
- Wanyu Liao
- Chen Zhen
- Jie Yao
View Affiliations

Affiliations: Department of Laboratory Medicine and Medical Research Center, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong 528308, P.R. China, Department of Pathology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong 528308, P.R. China
Published online on: May 27, 2022 https://doi.org/10.3892/ol.2022.13353
Article Number: 232

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung adenocarcinoma (LUAD) is a disease with high morbidity and mortality rates globally. Holliday junction‑recognizing protein (HJURP) has recently been shown to be a potentially useful biomarker for diagnosing and determining the progression and prognosis of different cancer types. The present study assessed the prognostic value of HJURP expression in LUAD and investigated the biological pathways related to HJURP that are involved in LUAD pathogenesis. It was found that high HJURP expression was significantly associated with stage (P=0.001), T grade (P=0.012) and N grade (P=0.012). Overall survival analysis demonstrated that patients with LUAD and high HJURP expression had a worse prognosis compared with those patients with low HJURP expression (P<0.001). Multivariate analysis using the Cox proportional hazards model indicated that the expression of HJURP [hazard ratio (HR), 1.32; 95% confidence interval (CI), 1.09‑1.60; P=0.004] and stage (HR, 1.90; 95% CI, 1.19‑3.03; P=0.007) were independent prognostic factors for patients with LUAD. Gene set enrichment analysis results showed that genes involved with ‘basal transcription factors’, the ‘cell cycle’, ‘homologous recombination’, ‘non‑small cell lung cancer’ (NSCLC), ‘oocyte meiosis’, ‘p53 signaling pathway’, ‘pathways in cancer’, ‘RNA degradation’ and ‘spliceosome’ were differentially enriched in the high HJURP expression phenotype. Significant correlations were also found between HJURP and several tumor‑infiltrating immune cells, immunomodulators and immune subtypes. Furthermore, western blotting and qPCR analyses confirmed that HJURP was significantly increased in cell lines of NSCLC. In summary, HJURP may be a potentially useful prognostic molecular biomarker of a poor prognosis in LUAD cases. Further experiments are needed to demonstrate the biological effects of HJURP.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
3	Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, et al: Somatic genomics and clinical features of lung adenocarcinoma: A retrospective study. PLoS Med. 13:e10021622016. View Article : Google Scholar : PubMed/NCBI
4	Shah DR and Masters GA: Precision medicine in lung cancer treatment. Surg Oncol Clin N Am. 29:15–21. 2020. View Article : Google Scholar : PubMed/NCBI
5	Ungureanu A, Zlatian O, Mitroi G, Drocaş A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii VN, et al: Staphylococcus aureus colonisation in patients from a primary regional hospital. Mol Med Rep. 16:8771–8780. 2017. View Article : Google Scholar : PubMed/NCBI
6	Zlatian O, Balasoiu AT, Balasoiu M, Cristea O, Docea AO, Mitrut R, Spandidos DA, Tsatsakis AM, Bancescu G and Calina D: Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections. Exp Ther Med. 16:4499–4510. 2018.PubMed/NCBI
7	Tanase A, Colita A, Ianosi G, Neagoe D, Branisteanu DE, Calina D, Docea AO, Tsatsakis A and Ianosi SL: Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant. Exp Ther Med. 12:2078–2082. 2016. View Article : Google Scholar : PubMed/NCBI
8	Foltz DR, Jansen LE, Bailey AO, Yates JR 3rd, Bassett EA, Wood S, Black BE and Cleveland DW: Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. Cell. 137:472–484. 2009. View Article : Google Scholar : PubMed/NCBI
9	Dunleavy EM, Roche D, Tagami H, Lacoste N, Ray-Gallet D, Nakamura Y, Daigo Y, Nakatani Y and Almouzni-Pettinotti G: HJURP is a cell-cycle-dependent maintenance and deposition factor of CENP-A at centromeres. Cell. 137:485–497. 2009. View Article : Google Scholar : PubMed/NCBI
10	Barnhart MC, Kuich PH, Stellfox ME, Ward JA, Bassett EA, Black BE and Foltz DR: HJURP is a CENP-A chromatin assembly factor sufficient to form a functional de novo kinetochore. J Cell Biol. 194:229–243. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kato T, Sato N, Hayama S, Yamabuki T, Ito T, Miyamoto M, Kondo S, Nakamura Y and Daigo Y: Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. Cancer Res. 67:8544–8553. 2007. View Article : Google Scholar : PubMed/NCBI
12	Mishra PK, Au WC, Choy JS, Kuich PH, Baker RE, Foltz DR and Basrai MA: Misregulation of Scm3p/HJURP causes chromosome instability in Saccharomyces cerevisiae and human cells. PLoS Genet. 7:e10023032011. View Article : Google Scholar : PubMed/NCBI
13	Shuaib M, Ouararhni K, Dimitrov S and Hamiche A: HJURP binds CENP-A via a highly conserved N-terminal domain and mediates its deposition at centromeres. Proc Natl Acad Sci U S A. 107:1349–1354. 2010. View Article : Google Scholar : PubMed/NCBI
14	Hu B, Wang Q, Wang Y, Chen J, Li P and Han M: Holliday junction-recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma. Onco Targets Ther. 10:2601–2607. 2017. View Article : Google Scholar : PubMed/NCBI
15	Valente V, Serafim RB, de Oliveira LC, Adorni FS, Torrieri R, Tirapelli DP, Espreafico EM, Oba-Shinjo SM, Marie SK, Paçó-Larson ML and Carlotti CG Jr: Modulation of HJURP (Holliday junction-recognizing protein) levels is correlated with glioblastoma cells survival. PLoS One. 8:e622002013. View Article : Google Scholar : PubMed/NCBI
16	Montes de Oca R, Gurard-Levin ZA, Berger F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO, Meseure D, et al: The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma. Mol Oncol. 9:657–674. 2015. View Article : Google Scholar : PubMed/NCBI
17	Li L, Li X, Meng Q, Khan AQ and Chen X: Increased expression of Holliday junction-recognizing protein (HJURP) as an independent prognostic biomarker in advanced-stage serous ovarian carcinoma. Med Sci Monit. 24:3050–3055. 2018. View Article : Google Scholar : PubMed/NCBI
18	Askar N, Cirpan T, Toprak E, Karabulut B, Selvi N, Terek MC, Uslu R, Sanli UA and Goker E: Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity. Int J Gynecol Cancer. 16:1552–1556. 2006. View Article : Google Scholar : PubMed/NCBI
19	Zeng C, Shao Z, Wei Z, Yao J, Wang W, Yin L, YangOu H and Xiong D: The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation. Cell Mol Biol Lett. 26:72021. View Article : Google Scholar : PubMed/NCBI
20	Moreno Leon L, Gautier M, Allan R, Ilié M, Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al: The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress. Oncogene. 38:7146–7165. 2019. View Article : Google Scholar : PubMed/NCBI
21	Ramos M, Franch P, Zaforteza M, Artero J and Durán M: Completeness of T, N, M and stage grouping for all cancers in the mallorca cancer registry. BMC Cancer. 15:8472015. View Article : Google Scholar : PubMed/NCBI
22	Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
23	Ru B, Wong CN, Tong Y, Zhong JY, Zhong SS, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, et al: TISIDB: An integrated repository portal for tumor-immune system interactions. Bioinformatics. 35:4200–4202. 2019. View Article : Google Scholar : PubMed/NCBI
24	Wei Y, Ouyang GL, Yao WX, Zhu YJ, Li X, Huang LX, Yang XW and Jiang WJ: Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling. Eur Rev Med Pharmacol Sci. 23:3847–3856. 2019.PubMed/NCBI
25	Zhou D, Tang W, Liu X, An HX and Zhang Y: Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer. Oncotarget. 8:43978–43989. 2017. View Article : Google Scholar : PubMed/NCBI
26	Dhieb D, Belguith I, Capelli L, Chiadini E, Canale M, Bravaccini S, Yangui I, Boudawara O, Jlidi R, Boudawara T, et al: Analysis of genetic alterations in tunisian patients with lung adenocarcinoma. Cells. 8:5142019. View Article : Google Scholar : PubMed/NCBI
27	Zheng MM, Li YS, Jiang BY, Tu HY, Tang WF, Yang JJ, Zhang XC, Ye JY, Yan HH, Su J, et al: Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC. J Thorac Oncol. 14:924–932. 2019. View Article : Google Scholar : PubMed/NCBI
28	Varn FS, Tafe LJ, Amos CI and Cheng C: Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy. Oncoimmunology. 7:e14310842018. View Article : Google Scholar : PubMed/NCBI
29	Wang W, Ren S, Wang Z, Zhang C and Huang J: Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Int Immunopharmacol. 78:1060772020. View Article : Google Scholar : PubMed/NCBI